Updated on 16 September 2020.
As of September 15th, ANVISA has terminated all emergency use pathways.
Emergo by UL consultants are monitoring the development of expedited regulatory routes in medical device markets worldwide. The situation is changing daily, and we encourage you to create a free RAMS account, where you can access real-time updates on COVID-19 regulatory developments from our international research team.
CREATE A FREE RAMS ACCOUNT >
Updated on 16 September 2020.